Literature DB >> 11975756

Age-related changes in human blood dendritic cell subpopulations.

N Teig1, D Moses, S Gieseler, U Schauer.   

Abstract

It is well known that the human immune system is functionally less mature at birth and, within the first years of life, undergoes a process of sequential development. Two subsets of dendritic cells (DCs) were identified in the blood: plasmacytoid and myeloid DCs. DCs stain negative for CD3, CD14, CD16, CD19, CD20 and CD56, and positive for human leucocyte antigen (HLA)-DR. In addition, plasmacytoid DCs strongly express CD123 while myeloid DCs express CD11. The number of the two different subsets was measured by flow cytometry in the peripheral blood from 44 healthy infants and children, aged 8 months to 18 years. While the number of CD11c+ myeloid cells (mean 11 cells/microl) did not change with age, the proportion of CD123+ plasmacytoid DCs decreased significantly (P < 0.001) from about 20 cells/microl to 8 cells/microl with age. In addition, we found a direct correlation between the number of plasmacytoid DC and interferon (IFN)-alpha production. As the two subsets of DC preferentially recognize different pathogens, age-related changes may have an impact on the maturation of the immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11975756     DOI: 10.1046/j.1365-3083.2002.01068.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  22 in total

Review 1.  Defective antigen-presenting cell function in human neonates.

Authors:  Paula A Velilla; Maria T Rugeles; Claire A Chougnet
Journal:  Clin Immunol       Date:  2006-09-28       Impact factor: 3.969

2.  Age-dependent changes in peripheral blood dendritic cell subsets in normal children and children with specific polysaccharide antibody deficiency (SPAD).

Authors:  Harumi Jyonouchi; Chongwei Cui; Lee Geng; Zhiwei Yin; Patricia Fitzgerald-Bocarsly
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

Review 3.  Understanding developmental pharmacodynamics: importance for drug development and clinical practice.

Authors:  Hussain Mulla
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

4.  The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life.

Authors:  O Vosters; C Lombard; F André; G Sana; E M Sokal; F Smets
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

5.  A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.

Authors:  Miguel L García-León; Laura C Bonifaz; Bogart Espinosa-Torres; Brenda Hernández-Pérez; Lino Cardiel-Marmolejo; José I Santos-Preciado; Rosa M Wong-Chew
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.

Authors:  Heather W Stout-Delgado; Xin Yang; Wendy E Walker; Bethany M Tesar; Daniel R Goldstein
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

Authors:  Xueqin Chen; Levi H C Makala; Yulan Jin; Diane Hopkins; Andy Muir; Nikhil Garge; Robert H Podolsky; Jin-Xiong She
Journal:  Clin Immunol       Date:  2008-09-30       Impact factor: 3.969

Review 8.  Optimization of immunotherapy in elderly cancer patients.

Authors:  Kei Tomihara; Tyler J Curiel; Bin Zhang
Journal:  Crit Rev Oncog       Date:  2013

9.  Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis.

Authors:  J Vakkila; A W Thomson; K Vettenranta; H Sariola; U M Saarinen-Pihkala
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.